[News Brief] REPROCELL Seeks Japan Approval for Stem Cell Therapy
REPROCELL has submitted an application for manufacturing and marketing approval in Japan for Stemchymal, a regenerative medicine product intended to…
Pharmaceuticals & Supplements
[News Brief] UCL and Eisai Extend Neurodegenerative Disease Research Partnership
University College London (UCL) and Eisai Co., Ltd. have signed a new agreement extending their collaboration in drug discovery and…
[News Brief] Sanyou Bio and Baiyunshan Xihe Partner on Radiopharmaceutical Development
Sanyou Biopharmaceutical and Guangzhou Baiyunshan Xihe Health Pharmaceutical have signed a strategic collaboration agreement to co-develop radiopharmaceutical and radiodiagnostic products…
[News Brief] Cadila Pharmaceuticals and Wellesta Holdings Sign Joint Venture MoU
Cadila Pharmaceuticals and Wellesta Holdings have signed a memorandum of understanding to establish a strategic joint venture focused on commercialising…
[News Brief] Mahidol University Partners with WE-WIN on Pharmaceutical Research
Mahidol University’s Faculty of Pharmacy and Taiwan’s WE-WIN Bio-Medical Co., Ltd. have signed a memorandum of understanding to strengthen collaboration…
[News Brief] CPHI South East Asia 2026 to Showcase Regional Pharma Partnerships
CPHI South East Asia 2026 will take place from 8 to 10 July 2026 at the Queen Sirikit National Convention…
[News Brief] The Purest Co Opens Johor Bahru Manufacturing Facility
Singapore-founded wellness brand The Purest Co has launched PurestLabs, its proprietary manufacturing facility in Johor Bahru, bringing its powder supplement…
[News Brief] DKSH Partners with Lilly in Hong Kong and Macau
DKSH Business Unit Healthcare has entered into a distribution and promotion agreement with Eli Lilly Export S.A. to sell, promote…
[News Brief] CanSinoBIO Receives Argentine Approval for Meningococcal Vaccine
CanSino Biologics Inc. has received a drug registration certificate from Argentina’s Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT)…
[News Brief] Anixa Biosciences Secures South Korean Patent for Breast Cancer Vaccine
Anixa Biosciences has announced that the Korean Ministry of Intellectual Property has granted a composition-of-matter patent for its breast cancer…